Ketamine for Adolescent Treatment-Resistant Depression

This study is designed for adolescents (age 12-18 years) with depression that has not improved with at least 2 medications.

Study activities include clinical interviews, 6 infusions of an experimental drug called Ketamine over 2 weeks, brain MRI scans and blood draws.


Intravenous Ketamine for Adolescents with Treatment-Resistant Depression: An Open-Label Study


Study team

Principal Investigator (PI):
Study Coordinator: